Electrophilic Agonists Modulate the Transient Receptor Potential Ankyrin-1 Channels Mediated by Insulin and Glucagon-like Peptide-1 Secretion for Glucose Homeostasis

This pre-clinical study investigated the transient receptor potential ankyrin-1 (TRPA1) channels on modulating targets for glucose homeostasis using agonists: the electrophilic agonists, cinnamaldehyde (CIN) and allyl isothiocyanate (AITC), and the non-electrophilic agonist, carvacrol (CRV). A gluco...

Full description

Saved in:
Bibliographic Details
Main Authors: Marisa Jadna Silva Frederico (Author), Andreza Cipriani (Author), Jocelyn Brice Alexandre Heim (Author), Ana Karla Bittencourt Mendes (Author), Marcela Aragón (Author), Joana Margarida Gaspar (Author), Nylane Maria Nunes De Alencar (Author), Fátima Regina Mena Barreto Silva (Author)
Format: Book
Published: MDPI AG, 2023-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a9abcf093a6e4019b0c2dcec0cc54f99
042 |a dc 
100 1 0 |a Marisa Jadna Silva Frederico  |e author 
700 1 0 |a Andreza Cipriani  |e author 
700 1 0 |a Jocelyn Brice Alexandre Heim  |e author 
700 1 0 |a Ana Karla Bittencourt Mendes  |e author 
700 1 0 |a Marcela Aragón  |e author 
700 1 0 |a Joana Margarida Gaspar  |e author 
700 1 0 |a Nylane Maria Nunes De Alencar  |e author 
700 1 0 |a Fátima Regina Mena Barreto Silva  |e author 
245 0 0 |a Electrophilic Agonists Modulate the Transient Receptor Potential Ankyrin-1 Channels Mediated by Insulin and Glucagon-like Peptide-1 Secretion for Glucose Homeostasis 
260 |b MDPI AG,   |c 2023-08-01T00:00:00Z. 
500 |a 10.3390/ph16081167 
500 |a 1424-8247 
520 |a This pre-clinical study investigated the transient receptor potential ankyrin-1 (TRPA1) channels on modulating targets for glucose homeostasis using agonists: the electrophilic agonists, cinnamaldehyde (CIN) and allyl isothiocyanate (AITC), and the non-electrophilic agonist, carvacrol (CRV). A glucose tolerance test was performed on rats. CIN and AITC (5, 10 and 20 mg/kg) or CRV (25, 100, 300, and 600 mg/kg) were administered intraperitoneally (i.p.), and glycemia was measured. In the intestine, Glucagon-like peptide-1 (GLP-1) and disaccharidase activity were evaluated (in vivo and in vitro, respectively). Furthermore, in vivo and in vitro insulin secretion was determined. Islets were used to measure insulin secretion and calcium influx. CIN and AITC improved glucose tolerance and increased insulin secretion in vivo and in vitro. CRV was unable to reduce glycemia. Electrophilic agonists, CIN and AITC, inhibited disaccharidases and acted as secretagogues in the intestine by inducing GLP-1 release in vivo and in vitro and contributed to insulin secretion and glycemia. The effect of CIN on calcium influx in pancreatic islets (insulin secretion) involves voltage-dependent calcium channels and calcium from stores. TRPA1 triggers calcium influx and potentiates intracellular calcium release to induce insulin secretion, suggesting that electrophilic agonists mediate this signaling transduction for the control of glycemia. 
546 |a EN 
690 |a nutrients 
690 |a intestinal hormone 
690 |a beta-cells 
690 |a calcium 
690 |a glycemia 
690 |a dissacharidase 
690 |a Medicine 
690 |a R 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceuticals, Vol 16, Iss 8, p 1167 (2023) 
787 0 |n https://www.mdpi.com/1424-8247/16/8/1167 
787 0 |n https://doaj.org/toc/1424-8247 
856 4 1 |u https://doaj.org/article/a9abcf093a6e4019b0c2dcec0cc54f99  |z Connect to this object online.